Aktis Oncology, Inc. Common stock (AKTS)
$27.00 +1.31% (delayed · 2026-09-04)
Research Aktis Oncology, Inc. Common stock (AKTS): delayed quotes, charts, headlines, earnings calendar events, and SEC 10-K / 10-Q / 8-K filings on tkrhub.
Aktis Oncology, Inc. Common stock (AKTS) $27.00 +1.31% — delayed US quotes, charts, news & SEC filings on tkrhub. PHARMACEUTICAL PREPARATIONS. Research only.
What you can review
- Delayed session quotes and daily charts
- Related headlines and press context
- Earnings / catalyst calendar windows
- SEC 10-K, 10-Q, and 8-K filings in-app
tkrhub is a US equity research desk — not a broker. Quotes are typically delayed ~15 minutes.